SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-19-000097
Filing Date
2019-11-21
Accepted
2019-11-21 09:08:56
Documents
4
Period of Report
2019-11-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k1.htm 8-K 38432
2 EXHIBIT 99.1 exhibit991pr.htm EX-99.1 12997
3 exhibit991pr001.jpg GRAPHIC 309577
4 exhibit991pr002.jpg GRAPHIC 272119
  Complete submission text file 0001401914-19-000097.txt   854386
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 191235872
SIC: 2834 Pharmaceutical Preparations